The present invention relates to novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.
本发明涉及新型視黃醇相關孤兒核受體γ(RORγ)調節劑及其在治療由RORγ介導的疾病中的使用。
US20140256740A1
申请人:——
公开号:——
公开(公告)日:——
[EN] COMPOUNDS AND METHODS<br/>[FR] COMPOSÉS ET MÉTHODES
申请人:TEMPERO PHARMACEUTICALS INC
公开号:WO2013019621A1
公开(公告)日:2013-02-07
The present invention relates to novel retinoid-related orphan receptor gamma (RORy) modulators and their use in the treatment of diseases mediated by RORy.
本发明涉及新型视黄醛酸相关孤儿受体γ(RORγ)调节剂及其在治疗由RORγ介导的疾病中的应用。
Concave Reagents, 21. Selective Acylations of Primary and Secondary Alcohols by Ketenes
作者:Wolfgang Schyja、Sönke Petersen、Ulrich Lüning
DOI:10.1002/jlac.199619961223
日期:1996.12
Concavepyridines 1 were used to catalyze the addition of primary and secondary alcohols to ketenes 4, and the kinetic data of these catalyses were determined. In inter- and intramolecular competitions the use of 1e–g led to improved selectivities for the acylation of primary alcohols in comparison with secondary alcohols. All primary alcohols react at comparable rates. Observed rate constants were